Oral insulinlike growth factor-I stimulates intestinal enzyme maturation in newborn rats

Life Sci. 1997;61(1):51-8. doi: 10.1016/s0024-3205(97)00357-3.

Abstract

Insulinlike growth factor-I (IGF-I) has been found in the milk of various species. To investigate if milk-borne IGF-I has any effect on postnatal gut development in neonatal animals, newborn rat pups were given orally 1 microg recombinant human IGF-I daily for 3 days. For comparison, a separate group of newborn pups was given 150 microg hydrocortisone, the hormone known to stimulate intestinal maturation in neonatal rats. Oral IGF-I treatment had no significant effect on the animal body weight nor on the weight of the stomach, small and large intestines, and pancreas. Oral administration of hydrocortisone significantly reduced body weight gain, but it had no apparent effect on internal organ weights. Both IGF-I and hydrocortisone treatments, however, significantly increased lactase, maltase and sucrase activities and hydrocortisone significantly increased aminopeptidase activity at the proximal small intestine when compared with the control. The finding supports the hypothesis that milk-borne IGF-I may play a role in regulating postnatal gut development in the suckling young.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn / physiology
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / pharmacology*
  • Intestines / drug effects*
  • Rats
  • Rats, Wistar
  • Sucrase / drug effects*
  • alpha-Glucosidases / drug effects*
  • beta-Galactosidase / drug effects*

Substances

  • Insulin-Like Growth Factor I
  • alpha-Glucosidases
  • beta-Galactosidase
  • Sucrase